| IPC 7 English version |
 A61P - A61P 15/18 |
| A61P01700-A61P04300 |
|
|
|
| SECTION A – HUMAN NECESSITIES |
|
| A 61 | MEDICAL OR VETERINARY SCIENCE; HYGIENE |
|
| A 61 P | THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS [7] |
|
17/ | 00 | Drugs for dermatological disorders [7] |
|
17/ | 02 | . | for treating wounds, ulcers, burns, scars, keloids, or the like [7] |
|
17/ | 04 | . | Antipruritics [7] |
|
17/ | 06 | . | Antipsoriatics [7] |
|
17/ | 08 | . | Antiseborrheics [7] |
|
17/ | 10 | . | Anti-acne agents [7] |
|
17/ | 12 | . | Keratolytics, e.g. wart or anti-corn preparations [7] |
|
17/ | 14 | . | for baldness or alopecia [7] |
|
17/ | 16 | . | Emollients or protectives, e.g. against radiation [7] |
|
19/ | 00 | Drugs for skeletal disorders [7] |
|
19/ | 02 | . | for joint disorders, e.g. arthritis, arthrosis [7] |
|
19/ | 04 | . | for non-specific disorders of the connective tissue [7] |
|
19/ | 06 | . | Antigout agents, e.g. antihyperuricemic or uricosuric agents [7] |
|
19/ | 08 | . | for bone diseases, e.g. rachitism, Paget's disease [7] |
|
19/ | 10 | . | . | for osteoporosis [7] |
|
21/ | 00 | Drugs for disorders of the muscular or neuromuscular system [7] |
|
21/ | 02 | . | Muscle relaxants, e.g. for tetanus or cramps [7] |
|
21/ | 04 | . | for myasthenia gravis [7] |
|
21/ | 06 | . | Anabolic agents (androgens A61P 5/26) [7] |
|
23/ | 00 | Anaesthetics [7] |
|
23/ | 02 | . | Local anaesthetics [7] |
|
25/ | 00 | Drugs for disorders of the nervous system [7] |
|
25/ | 02 | . | for peripheral neuropathies [7] |
|
25/ | 04 | . | Centrally acting analgesics, e.g. opioids [7] |
|
25/ | 06 | . | Antimigraine agents [7] |
|
25/ | 08 | . | Antiepileptics; Anticonvulsants [7] |
|
25/ | 10 | . | . | for petit-mal [7] |
|
25/ | 12 | . | . | for grand-mal [7] |
|
25/ | 14 | . | for treating abnormal movements, e.g. chorea, dyskinesia [7] |
|
25/ | 16 | . | . | Anti-Parkinson drugs [7] |
|
25/ | 18 | . | Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia [7] |
|
25/ | 20 | . | Hypnotics; Sedatives [7] |
|
25/ | 22 | . | Anxiolytics [7] |
|
25/ | 24 | . | Antidepressants [7] |
|
25/ | 26 | . | Psychostimulants, e.g. nicotine, cocaine [7] |
|
25/ | 28 | . | for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia [7] |
|
25/ | 30 | . | for treating abuse or dependence [7] |
|
25/ | 32 | . | . | Alcohol-abuse [7] |
|
25/ | 34 | . | . | Tobacco-abuse [7] |
|
25/ | 36 | . | . | Opioid-abuse [7] |
|
27/ | 00 | Drugs for disorders of the senses [7] |
|
27/ | 02 | . | Ophthalmic agents [7] |
|
27/ | 04 | . | . | Artificial tears; Irrigation solutions [7] |
|
27/ | 06 | . | . | Antiglaucoma agents or miotics [7] |
|
27/ | 08 | . | . | Mydriatics or cycloplegics [7] |
|
27/ | 10 | . | . | for accommodation disorders, e.g. myopia [7] |
|
27/ | 12 | . | . | for cataracts [7] |
|
27/ | 14 | . | . | Decongestants or antiallergics [7] |
|
27/ | 16 | . | Otologicals [7] |
|
29/ | 00 | Non-central analgesic, antipyretic or antiinflammatory agents, e.g antirheumatic agents; Non-steroidal antiinflammatory drugs (NSAIDs) [7] |
|
29/ | 02 | . | without antiinflammatory effect [7] |
|
31/ | 00 | Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics [7] |
|
31/ | 02 | . | Local antiseptics [7] |
|
31/ | 04 | . | Antibacterial agents [7] |
|
31/ | 06 | . | . | for tuberculosis [7] |
|
31/ | 08 | . | . | for leprosy [7] |
|
31/ | 10 | . | Antimycotics [7] |
|
31/ | 12 | . | Antivirals [7] |
|
31/ | 14 | . | . | for RNA viruses [7] |
|
31/ | 16 | . | . | . | for influenza or rhinoviruses [7] |
|
31/ | 18 | . | . | . | for HIV [7] |
|
31/ | 20 | . | . | for DNA viruses [7] |
|
31/ | 22 | . | . | . | for herpes viruses [7] |
|
33/ | 00 | Antiparasitic agents [7] |
|
33/ | 02 | . | Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis [7] |
|
33/ | 04 | . | . | Amoebicides [7] |
|
33/ | 06 | . | . | Antimalarials [7] |
|
33/ | 08 | . | . | for Pneumocystis carinii [7] |
|
33/ | 10 | . | Anthelmintics [7] |
|
33/ | 12 | . | . | Schistosomicides [7] |
|
33/ | 14 | . | Ectoparasiticides, e.g. scabicides [7] |
|
35/ | 00 | Antineoplastic agents [7] |
|
35/ | 02 | . | specific for leukemia [7] |
|
35/ | 04 | . | specific for metastasis [7] |
|
37/ | 00 | Drugs for immunological or allergic disorders [7] |
|
37/ | 02 | . | Immunomodulators [7] |
|
37/ | 04 | . | . | Immunostimulants [7] |
|
37/ | 06 | . | . | Immunosuppressants, e.g. drugs for graft rejection [7] |
|
37/ | 08 | . | Antiallergic agents (antiasthmatic agents A61P 11/06; ophthalmic antiallergics A61P 27/14) [7] |
|
39/ | 00 | General protective or antinoxious agents [7] |
|
39/ | 02 | . | Antidotes [7] |
|
39/ | 04 | . | Chelating agents [7] |
|
39/ | 06 | . | Free radical scavengers or antioxidants [7] |
|
41/ | 00 | Drugs used in surgical methods, e.g. surgery adjuvants for preventing adhesion or for vitreum substitution [7] |
|
43/ | 00 | Drugs for specific purposes, not provided for in groups A61P 1/00 to A61P 41/00 [7] |
|
| A61P - A61P 15/18 |  |
